InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,409.60
(
1.26%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.57
(
-0.40%
)
Bitcoin
65,559.78
(
-1.39%
)
Post# of 252233
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

alertmeipp

Send PM Follow Ignore
Followers 12
Posts 2643
Boards Moderated 0
Alias Born 07/18/2006

alertmeipp

Re: DewDiligence post# 249469

Wednesday, 01/31/2024 6:17:32 PM

Wednesday, January 31, 2024 6:17:32 PM

Post# of 252233
$RVNC - down 20 percent last two days

Can the market be more negative on this one?

Supposed to be best in class drug.

EOLS which is selling an inferior product is having EV of 810mm with 2024 revenue guidance of 255mm. 3.2x multiple

RVNC minimum revenue guidance is 280mm. EV is 670mm. 2.4x.

I.e. the market is saying EOLS has better prospect than RVNC now. Make no sense to me.

Is it really that hard to roll out a product properly? They seems to execute well with RHA. How can they perform so messy with Daxxify?

Should Foley be fired?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up